Matthew Emmens, Chief Executive Officer, Angus Russell, Chief Financial Officer, Mike Cola, President, Specialty Pharmaceuticals and Sylvie Grégoire, President, Human Genetic Therapies hosted the investor and analyst meeting.
Full Year 2007 Press Release
Slide presentation to accompany the call
Replay of the audio webcast**.
* Slides number 33 & 34 revised on March 5, 2008 to clarify exclusivity of certain products
** Email verification is required